Clinical Genitourinary Cancer


Publication Venue For

  • Synchronous Malignancies Identified by 18F-fluciclovine Positron Emission Tomography for Prostate Cancer: Case Series and Mini-Review.  19:e37-e40. 2021
  • Association of mTOR Pathway Markers and Clinical Outcomes in Patients with Intermediate-/High-risk Prostate Cancer: Long-Term Analysis.  17:366-372. 2019
  • Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of “Recurrence”.  17:209-215.e1. 2019
  • Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial Carcinoma.  16:e751-e760. 2018
  • Patterns of Regional Lymphadenectomy for Clinically Node-negative Patients With Penile Carcinoma: Analysis From the National Cancer Database From 1998 to 2012.  15:670-677.e1. 2017
  • Immune Check Point Inhibition in Sarcomatoid Renal Cell Carcinoma: A New Treatment Paradigm..  15:e897-e901. 2017
  • Prevalence of Measurable Disease in Metastatic Castration-resistant Prostate Cancer.  15:534-539. 2017
  • Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study.  14:e515-e520. 2016
  • Effect of African-American Race on Tumor Recurrence after Radical Cystectomy for Urothelial Carcinoma of the Bladder.  13:469-475. 2015
  • Zonal NePhRO scoring system: A superior renal tumor complexity classification model.  12. 2014
  • Six-month progression-free survival as the primary endpoint to evaluate the activity of new agents as second-line therapy for advanced urothelial carcinoma.  12:130-137. 2014
  • The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: A call for standardized methods for immunohistochemical evaluation.  5:264-270. 2007
  • Patient preferences in prostate cancer: A clinician's guide to understanding health utilities.  4:15-23. 2005
  • Ethnic variation in localized prostate cancer: A pilot study of preferences, optimism, and quality of life among black and white veterans.  3:31-37. 2004
  • Pilot study of a utilities-based treatment decision intervention for prostate cancer patients.  1:105-114. 2002
  • International Standard Serial Number (issn)

  • 1540-0352
  • 1558-7673
  • Electronic International Standard Serial Number (eissn)

  • 1938-0682